MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS AFTER POST-TRANSPLANT HEPATOCELLULAR CARCINOMA RECURRENCE: IS IT TOO LATE?
2020
Mammalian target of rapamycin inhibitors after post-transplant hepatocellular carcinoma recurrence: Is it too late?
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI